Ferrochelatase Antibodies

Santa Cruz Biotechnology features a diverse variety of Ferrochelatase monoclonal antibodies for research in understanding this crucial enzyme. Ferrochelatase Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ferrochelatase is an essential enzyme in the heme biosynthesis pathway, catalyzing the insertion of ferrous iron into protoporphyrin IX to form heme. The process is vital for the production of hemoglobin and other heme-containing proteins, which play critical roles in oxygen transport and cellular respiration. Dysregulation of Ferrochelatase can lead to various hematological disorders and has implications in diseases such as porphyria and anemia. Research into Ferrochelatase activity provides insights into heme metabolism and its associated pathologies. Understanding Ferrochelatase function helps advance knowledge of metabolic disorders and potential therapeutic approaches. Investigating the regulation of Ferrochelatase expression reveals new perspectives on cellular iron homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of heme biosynthesis and related diseases.